We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-15.32%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$72.6B
AUM Growth
-$10.7B
Cap. Flow
+$3.99B
Cap. Flow %
5.5%
Top 10 Hldgs %
8.92%
Holding
4,217
New
541
Increased
1,544
Reduced
1,324
Closed
497

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$453M
2
ORCL icon
Oracle
ORCL
+$431M
3
AAPL icon
Apple
AAPL
+$376M
4
SLB icon
SLB Ltd
SLB
+$353M
5
TWTR
Twitter, Inc.
TWTR
+$335M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$746M
2
AET
Aetna Inc
AET
+$378M
3
NVDA icon
NVIDIA
NVDA
+$348M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$307M
5
T icon
AT&T
T
+$275M

Sector Composition

Rank Sector Weight
1 Technology 15.42%
2 Consumer Discretionary 11.75%
3 Healthcare 11.33%
4 Financials 7.58%
5 Communication Services 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESV
3526
CALL
DELISTED
Ensco Rowan plc
ESV
$178K ﹤0.01%
12,500
TFSL icon
3527
TFS Financial
TFSL
$4.95B
$177K ﹤0.01%
10,996
-9,302
-46% -$143K
VG
3528
DELISTED
Vonage Holdings Corporation
VG
$176K ﹤0.01%
20,176
-193,725
-91% -$2.22M
CTSO icon
3529
Cytosorbents Corp
CTSO
$23.3M
$174K ﹤0.01%
+21,583
New +$214K
ICL icon
3530
ICL Group
ICL
$7.42B
$174K ﹤0.01%
30,679
-86
-0.3% -$509
ACET
3531
DELISTED
Aceto Corp
ACET
$174K ﹤0.01%
206,525
+194,725
+1,650% +$349K
PRSP
3532
CALL
DELISTED
Perspecta Inc. Common Stock
PRSP
$172K ﹤0.01%
10,000
LILAK icon
3533
Liberty Latin America Class C
LILAK
$1.64B
$171K ﹤0.01%
13,691
-391,162
-97% -$6.03M
ANGI icon
3534
PUT
Angi Inc
ANGI
$200M
$170K ﹤0.01%
+1,060
New +$192K
IVR icon
3535
Invesco Mortgage Capital
IVR
$805M
$170K ﹤0.01%
+1,172
New +$177K
NPTN
3536
DELISTED
NEOPHOTONICS CORP
NPTN
$170K ﹤0.01%
26,209
-176,896
-87% -$1.35M
MDR
3537
DELISTED
McDermott International
MDR
$170K ﹤0.01%
26,000
-10,611
-29% -$112K
ORIT
3538
DELISTED
Oritani Financial Corp. New
ORIT
$169K ﹤0.01%
+11,450
New +$173K
STML
3539
DELISTED
Stemline Therapeutics, Inc.
STML
$168K ﹤0.01%
17,675
-85,939
-83% -$1.11M
RCKT icon
3540
Rocket Pharmaceuticals
RCKT
$388M
$165K ﹤0.01%
11,166
-13,890
-55% -$231K
USX
3541
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$165K ﹤0.01%
+29,363
New +$247K
PVTL
3542
DELISTED
Pivotal Software, Inc.
PVTL
$165K ﹤0.01%
+10,096
New +$181K
UA icon
3543
PUT
Under Armour Class C
UA
$2.25B
$162K ﹤0.01%
10,000
UNFI icon
3544
PUT
United Natural Foods
UNFI
$2.94B
$159K ﹤0.01%
+15,000
New +$315K
PRMW
3545
DELISTED
Primo Water Corporation
PRMW
$158K ﹤0.01%
11,266
-116,099
-91% -$1.78M
GRTS
3546
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$157K ﹤0.01%
+10,130
New +$193K
BZH icon
3547
CALL
Beazer Homes USA
BZH
$883M
$154K ﹤0.01%
16,200
-11,800
-42% -$117K
VGR
3548
DELISTED
Vector Group Ltd.
VGR
$154K ﹤0.01%
+23,408
New +$198K
NVAX icon
3549
Novavax
NVAX
$1.46B
$152K ﹤0.01%
4,139
-278
-6% -$10.8K
PAAS icon
3550
CALL
Pan American Silver
PAAS
$22.2B
$152K ﹤0.01%
10,400

Similar funds

David Shaw's Q4 2018 Portfolio in Review

As of Q4 2018, David Shaw held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

David Shaw deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.

  • David Shaw's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
  • David Shaw added most to Oracle in Q4 2018, an estimated $431M increase.
  • David Shaw's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
  • David Shaw fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
  • David Shaw's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
  • David Shaw opened 541 new positions and closed 497 in Q4 2018.
  • David Shaw's portfolio value fell 13% quarter-over-quarter to $72.6B.

Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.